Clinical Trial Update: Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing irinotecan-based therapy with LoHP versus a 5-FU/leucovorin/LoHP regimen as first-line treatment in gastric cancer has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CPT-11 (irinotecan) (irinotecan)
• LOHP

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED